EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical Significance of Indeterminate Antibody to Hepatitis C in Cancer Patients

Joanne Arvelaez Pascucci, Khalis Mustafayev, Ying Jiang, Issam Raad, Eduardo Yepez Guevara, Harrys A. Torres

Journal of Viral Hepatitis · 2026-12 · 33 (12)

DOI: 10.1111/jvh.70257 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Most patients with cancer are screened for hepatitis C virus (HCV) infection using an antibody to HCV (anti‐HCV) test. However, the importance of an indeterminate anti‐HCV result is unknown. We investigated the clinical significance of an indeterminate anti‐HCV result in cancer patients. We conducted a retrospective cohort study of cancer patients screened for HCV infection using ARCHITECT Anti‐HCV at our institution between October 2016 and July 2024. Patients were categorized based on their anti‐HCV results as patients with indeterminate anti‐HCV and undetectable HCV‐RNA in the absence of HCV treatment, and patients with reactive anti‐HCV and chronic infection. We compared the two groups using univariable analyses and multivariable logistic regression analysis. Of the 112,180 patients screened with anti‐HCV, 114 (0.1%) had indeterminate results; 101 of them with confirmed cancer were further analysed. Anti‐HCV testing was repeated in 24 (24%) patients; most (84%) had non‐reactive (46%) or indeterminate (38%) results. Among the 101 patients with indeterminate anti‐HCV, 98 (97%) did not have proven HCV infection, but 3 (3%) had HCV infection. Multivariable analysis showed that male sex (adjusted odds ratio [aOR] 2.22, 95% confidence interval [CI] 1.40–3.53, p < 0.001), age ≥ 60 years (aOR 1.61, 95% CI 1.01–2.56, p = 0.046), hepatitis B or HIV coinfection (aOR 3.13, 95% CI 1.21–8.11, p = 0.019) and cirrhosis (aOR 6.67, 95% CI 2.05–21.69, p = 0.002) were more likely to have chronic than an indeterminate anti‐HCV result. Indeterminate anti‐HCV results are uncommon in cancer patients and rarely indicate HCV infection.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →